268 filings
Page 10 of 14
EFFECT
2n8 pgantosa4xw1d9
23 Aug 17
Notice of effectiveness
12:00am
CORRESP
6s40if
21 Aug 17
Correspondence with SEC
12:00am
UPLOAD
78bx k0w8regctebfiwk
14 Aug 17
Letter from SEC
12:00am
S-3
79t3w5hn0w o0bns
9 Aug 17
Shelf registration
12:00am
8-K
tq3hm
8 Aug 17
Zafgen Reports Second Quarter 2017 Financial Results
12:00am
8-K
ozm6dew l8
23 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
sr280gk98ooxjkrchkn
9 May 17
Zafgen Reports First Quarter 2017 Financial Results
12:00am
8-K
yil75cy
4 May 17
Zafgen Announces Positive Topline Phase 1 Data for ZGN-1061, a Second Generation MetAP2 Inhibitor
12:00am
S-8
whcdimz88doc7i
10 Mar 17
Registration of securities for employees
12:00am
8-K
zcmpx9dqtb
9 Mar 17
Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
r8bs2eqijbdfey
9 Nov 16
Zafgen Reports Third Quarter 2016 Financial Results
12:00am
8-K
1rbjsc52r uami2p4g3
4 Aug 16
Zafgen Reports Second Quarter 2016 Financial Results
12:00am
8-K
thgrc
19 Jul 16
Zafgen Refocuses Resources on Development of Differentiated Second-Generation MetAP2 Inhibitor ZGN-1061
12:00am
8-K
rjxp4lfl l77jj1
1 Jul 16
Departure of Directors or Certain Officers
12:00am